jump to content

Fachbereich Veterinärmedizin


Service-Navigation

    Publication Database

    Limiting factors in treatment success of biofilm-forming Streptococci in the case of canine infective endocarditis caused by Streptococcus canis (2023)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Katsburg, Miriam (WE 7)
    Weingart, Christiane (WE 20)
    Aubry, Etienne (WE 7)
    Kershaw, Olivia (WE 12)
    Kikhney, Judith
    Kursawe, Laura
    Lübke-Becker, Antina (WE 7)
    Moter, Annette
    Skrodzki, Marianne (WE 20)
    Kohn, Barbara (WE 20)
    Fulde, Marcus (WE 7)
    Quelle
    Veterinary sciences
    Bandzählung: 10
    Heftzählung: 5
    Seiten: Artikel 314
    ISSN: 2306-7381
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://www.mdpi.com/2306-7381/10/5/314
    DOI: 10.3390/vetsci10050314
    Pubmed: 37235397
    Kontakt
    Institut für Mikrobiologie und Tierseuchen

    Robert-von-Ostertag-Str. 7-13
    14163 Berlin
    +49 30 838 51843 / 66949
    mikrobiologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    An 8-year-old male Rhodesian Ridgeback was presented with fever and severe thrombocytopenia. Clinical and laboratory examination, echocardiography, blood culture, and pathohistology revealed evidence of infective endocarditis, ischemic renal infarcts, and septic encephalitis. Treatment was started immediately but the dog's condition worsened, and the dog had to be euthanized. The causative Streptococcus canis strain was detected by blood culture and MALDI-TOF MS and analyzed using whole-genome sequencing and multilocus sequence typing. Antibiotic susceptibility testing did not detect any resistance. The affected heart valve was analyzed using FISH imaging, which showed a streptococcal biofilm on the heart valve. Bacteria in biofilms are recalcitrant to antibiotic treatment. Early diagnosis could be beneficial to treatment outcome. Treatment of endocarditis could be improved by researching the optimal dosage of antibiotics in conjunction with the use of biofilm-active drugs.